Loading
Latest filing published 09 May 2023 for CRESCENT BIOPHARMA, INC., €19k. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Only one filing by Bruce S. Johnson is known so far (9 May 2023): an open-market purchase, €19k, in Crescent Biopharma, Inc. That is too little to draw conclusions. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration